Spring Bank Pharmaceuticals, Inc. (SBPH) has 44 open-market insider trades by 9 insiders since 2016. The most active filer is Martin J. Driscoll, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kurt M. Eichler | Dir | — | 10 | $1.7M | 2019-12-30 |
| Martin J. Driscoll | CEOPres | — | 20 | $613K | 2020-11-20 |
| Nezam H. Afdhal | Chief Medical Officer | — | 5 | $162K | 2016-11-23 |
| Jonathan Freve | Treasurer | — | 4 | $63K | 2019-11-14 |
| Scott Andrew Smith | Dir | — | 1 | $49K | 2019-12-31 |
| David Arkowitz | Dir | — | 1 | $31K | 2019-12-31 |
| Radhakrishnan P. Iyer | Chief Scientific Officer | — | 1 | $833 | 2020-11-20 |
| Lori Firmani | Treasurer | — | 1 | $833 | 2020-11-20 |
| Garrett Winslow | Secretary | — | 1 | $833 | 2020-11-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Martin J. Driscoll | President | Sell | $833 | 2020-11-20 |
| Kurt M. Eichler | Director | Sell | $50K | 2019-12-30 |
| Jonathan Freve | Treasurer | Buy | $15K | 2019-11-14 |
| Martin J. Driscoll | President | Buy | $14K | 2019-11-13 |
| Scott Andrew Smith | Director | Buy | $49K | 2019-06-28 |
| Jonathan Freve | Treasurer | Buy | $27K | 2019-05-29 |
Companies that share insiders with SBPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Martin J. Driscoll | CEO & President | Buy | $60K | 2019-05-29 |
| Martin J. Driscoll | President | Buy | $33K | 2019-05-21 |
| Martin J. Driscoll | President | Buy | $73K | 2019-04-30 |
| Martin J. Driscoll | President | Buy | $48K | 2018-08-13 |
| Martin J. Driscoll | President | Buy | $13K | 2018-02-28 |
| Martin J. Driscoll | President | Buy | $15K | 2017-09-14 |
| David Arkowitz | Director | Buy | $31K | 2017-08-04 |
| Martin J. Driscoll | President | Buy | $25K | 2017-08-03 |
| Kurt M. Eichler | Director | Buy | $1000K | 2017-06-27 |